At Market Issuance Sales AgreementARYx Therapeutics, Inc. • May 20th, 2010 • Pharmaceutical preparations • New York
ARYx Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC, a Delaware limited liability company (“MLV”), and Wm Smith & Co., a Colorado corporation (“Wm Smith” and, together with MLV, the “Agents”), as follows:
